Damora Therapeutics (DMRA) Free Cash Flow Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 137.65% |
| 10 | Damora Therapeutics | 853.36 Mn | 650.97 Mn | - | -758.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -758.33% |
| Dec 31, 2025 | 111.68% |
| Sep 30, 2025 | 29.48% |
| Jun 30, 2025 | 43.90% |
| Mar 31, 2025 | 59.32% |
| Dec 31, 2024 | 57.14% |
| Sep 30, 2024 | 56.39% |
| Jun 30, 2024 | 47.99% |
| Mar 31, 2024 | 35.16% |
| Dec 31, 2023 | 0.23% |
| Sep 30, 2023 | 15.33% |
| Jun 30, 2023 | 46.79% |
| Mar 31, 2023 | -33.04% |
| Dec 31, 2022 | 35.55% |
| Sep 30, 2022 | -8.46% |
| Jun 30, 2022 | -31.28% |
| Mar 31, 2022 | 51.89% |
| Dec 31, 2021 | -22.79% |
| Sep 30, 2021 | -7.33% |
| Jun 30, 2021 | -58.24% |
| Mar 31, 2021 | -78.19% |
| Dec 31, 2020 | -176.36% |